Filing Details
- Accession Number:
- 0001209191-21-070631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-20 18:00:27
- Reporting Period:
- 2021-12-16
- Accepted Time:
- 2021-12-20 18:00:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1601830 | Recursion Pharmaceuticals Inc. | RXRX | Biological Products, (No Disgnostic Substances) (2836) | 464099738 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1856414 | Marriott Tina Larson | 41 S. Rio Grande Street Salt Lake City UT 84101 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2021-12-16 | 1,160 | $18.09 | 48,840 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-16 | 1,040 | $19.17 | 47,800 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2021-12-16 | 300 | $19.78 | 47,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Sales are pursuant to a 10b5-1 trading plan established by the Reporting Person.
- The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $17.63 to $18.53 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $18.69 to $19.55 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $19.69 to $19.93 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.